No Data
No Data
Why Investors Shouldn't Be Surprised By Evolent Health, Inc.'s (NYSE:EVH) Low P/S
Press Release: Define Ventures Appoints Carolyn Magill as Venture Partner
Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock
Evolent Health Is Maintained at Overweight by JP Morgan
Evolent Health Analyst Ratings
J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $12
151798759 OP : sonething is up… fingers crossed